Allosteric modulators for
human health
About us
Addex Corporate Presentation
Overview
Our people
Executive Officers
Non-Executive Directors
Contact
Privacy Policy
Careers
Pipeline
Clinical and Pre-Clinical Pipeline
Research And Development
Technology
Allosteric modulation
Publications
Partners & collaboration
Investors
Addex Corporate Presentation
Stock Data
Press releases
Ad hoc announcements (Art. 53 L.R)
Events
Financial Reports
Analyst Reports
General Meetings
SEC / SIX Filings
Guide to US ADSS for Six Shareholders
Register for email news
Corporate Governance
Contact
Media
Press releases
Contact
Press releases
All Years
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
Please select year
10.19
2011
Addex to Present in NYC at the Newsmakers in the Biotech Industry conference hosted by BioCentury and Thomson Reuters
10.03
2011
Addex to Present Progress on Multiple Allosteric Modulator Programs for Neurodegenerative and other Neurological Disorders
09.26
2011
Addex to Present at the Jefferies 2011 Global Healthcare Conference in London
09.02
2011
Addex Regains Rights to Parkinson’s Drug Candidates from Merck
08.15
2011
Addex Pharmaceuticals Appoints Dr Bharatt Chowrira as CEO
08.11
2011
Addex Pharmaceuticals Announces Board Changes
07.27
2011
Addex Pharmaceuticals First Half 2011 Financial Results
07.20
2011
Addex Pharmaceuticals First Half Financial Results on July 27
07.07
2011
Addex Announces Corporate Reorganization and Restructuring Initiative to Strengthen Its Leadership Position in Allosteric Modulation-Based Drug Discovery and Development Focus on Core R&D Programs
06.03
2011
Addex Pharmaceuticals CEO Steps Down
Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
Next
Back